Company intelligence / Profile preview
Becanex
Berlin Friedrichshain / Adlershof, Berlin, Germanybecanex.com ↗
- Ownership
- Private
- Employees
- ~15
- Development stage
- Other
01
Overview
Becanex has developed a patented One-Step extraction process to produce plant-identical full-spectrum cannabinoid extracts with high terpene diversity. The company transitioned to the medical cannabis market in 2023 and offers both full-spectrum and THC-free broad-spectrum CBD oils. Clinical results are not yet published; products are available commercially in food/cosmetics sectors while pharmaceutical development continues.
- Therapeutic areas
- OtherNeurology
- Modalities
- Small molecule (cannabinoids such as CBD, CBG, CBC)Plant extract
- Industry
- Biotech
02
Drug pipeline
7 assets6 more assets in the full pipeline.
03
Partnerships
Phytonext (technology partner)
Beyond the preview
Go deeper on Becanex.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Becanex.